MedPath

EFFECT OF AN ANTI-OXIDANT TREATMENT ON RESISTIN SERUM LEVELS.A RANDOMISED STUDY

Conditions
Data suggesting participation of resistin, a new discovered protein, whose biological significance is still uncertain, in oxidative processes have been sporadically published. One is tempted to speculate that mononuclear blood cells would release this protein into the systemic circulation, where it acts as a buffer system, with some anti-oxidant mechanism. Consequently, a treatment with antioxidant substances (vitamin C) might reduce resistin levels.
MedDRA version: 6.1Level: PTClassification code 10022489
Registration Number
EUCTR2005-002368-27-IT
Lead Sponsor
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Main Objective: ;Secondary Objective: ;Primary end point(s):
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath